Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

These semaglutide drugs became so popular after their efficacy for weight loss became apparent that, in a sense, they became ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 ...

Novo has been hit by copycats of its GLP-1 drugs Wegovy for weight-loss and Ozempic for diabetes. US law bars pharmacies from ...

Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including Ozempic and Wegovy, ...

About 2% of U.S. adults use GLP-1 drugs, but results vary. Diet, exercise, and mental health remain key to long-term success.

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.